Surgery Doctors in Greenville, MS Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Philip D Doolittle, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1214 Hospital St, Greenville, MS 38703 Phone: 662-335-9283    Fax: 662-334-6989

Hugh A Gamble Ii, MD Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 344 Arnold Ave, Greenville, MS 38701 Phone: 662-332-8131    Fax: 662-334-4478

Dr. John Carroll Sandefur, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 313 Arnold Ave, Suite A, Greenville, MS 38701 Phone: 662-332-5151    Fax: 662-332-5152

Jeffery Samuel Doolittle, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1214 Hospital St, Greenville, MS 38703 Phone: 662-335-9283

News Archive

Nutranomics releases results of human patient clinical studies regarding Glucozyme

Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the results of human patient clinical studies undertaken by the Company regarding Glucozyme™ are nearing a public release date.

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Today AIDS Healthcare Foundation (AHF) decried the fact that the recent campaign by Gilead Sciences Inc. to obtain approval by the U.S. Food & Drug Administration for Truvada as PrEP (pre-exposure prophylaxis) has led to a "black market" for the drug in Florida.

Pennsylvania Patient Safety Advisory for 2010 December focusses on tackling norovirus outbreaks

In early 2010, Pennsylvania nursing homes and hospitals reported an increased number of cases of gastrointestinal illness which are consistent with recurring outbreaks of the highly contagious norovirus and norovirus-like illnesses nationwide. With a new norovirus season approaching, the Pennsylvania Patient Safety Authority issues its 2010 December Pennsylvania Patient Safety Advisory with data analysis, guidance and success stories provided by Pennsylvania nursing homes for preventing and controlling the illness.

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.

Read more Medical News

› Verified 6 days ago